These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12762289)

  • 1. Coronary heart disease in HIV-infected persons.
    Glesby MJ
    AIDS Read; 2003 Apr; 13(4 Suppl):S15-9. PubMed ID: 12762289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia and coronary heart disease: management issues from Indian perspective.
    Gambhir DS; Gambhir JK; Sudha R
    Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Behrens GM
    N Engl J Med; 2005 Apr; 352(16):1721-2; author reply 1721-2. PubMed ID: 15843678
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV protease inhibitors and dyslipidemia.
    Clotet B; Negredo E
    AIDS Rev; 2003; 5(1):19-24. PubMed ID: 12875104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.
    Martínez E; Tuset M; Milinkovic A; Miró JM; Gatell JM
    Antivir Ther; 2004 Oct; 9(5):649-63. PubMed ID: 15535403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation and management of dyslipidemia in HIV-infected patients.
    Fichtenbaum CJ
    AIDS Clin Care; 2001 Dec; 13(12):113-7, 120. PubMed ID: 11769116
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy.
    Fredriksen J; Ueland T; Dyrøy E; Halvorsen B; Melby K; Melbye L; Skalhegg BS; Bohov P; Skorve J; Berge RK; Aukrust P; Frøland SS
    Eur J Clin Invest; 2004 Oct; 34(10):709-15. PubMed ID: 15473896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of dyslipidemia and other cardiovascular risk factors in HIV-infected patients: case-based review.
    Aberg JA
    Top HIV Med; 2006; 14(4):134-9. PubMed ID: 17114827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atazanavir found to help improve lipid profile. IDSA study offers good news for HIV care.
    AIDS Alert; 2003 Jan; 18(1):7-8. PubMed ID: 12541995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
    Calza L; Manfredi R; Chiodo F
    J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hyperlipidemia in patients with coronary heart disease].
    Tikkanen MJ; Miettinen T
    Duodecim; 1992; 108(19):1649-52. PubMed ID: 1366190
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
    Martínez E; Domingo P; Ribera E; Milinkovic A; Arroyo JA; Conget I; Pérez-Cuevas JB; Casamitjana R; de Lazzari E; Bianchi L; Montserrat E; Roca M; Burgos R; Arnaiz JA; Gatell JM
    Antivir Ther; 2003 Oct; 8(5):403-10. PubMed ID: 14640387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia].
    Zakharov VN
    Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342
    [No Abstract]   [Full Text] [Related]  

  • 15. The VA HDL intervention trial: clinical implications.
    Rubins HB; Collins D; Robins SJ
    Eur Heart J; 2000 Jul; 21(14):1113-5. PubMed ID: 10924289
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary artery disease and human immunodeficiency virus infection.
    Passalaris JD; Sepkowitz KA; Glesby MJ
    Clin Infect Dis; 2000 Sep; 31(3):787-97. PubMed ID: 11017831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
    Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC
    J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications and side effects. Crestor tested in PHAs.
    TreatmentUpdate; 2005; 17(4):6-7. PubMed ID: 17230630
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipoproteins HDL and coronary artery disease: a molecular mechanism of fibrate].
    Kaletha K; Chodorowski Z; Anand IS; Rybakowska I; Nagel-Starczynowska G
    Przegl Lek; 2003; 60(4):223-5. PubMed ID: 14569888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eiconol effects on hemocoagulation in coronary heart disease patients].
    Dzhanashiia PK; Panchenko VM; Nazlukhanian SO; Chernova GI; Liutova LV; Semenov VA; Korneenkov VK; Perekrestova EI; Nurmukhamedov SA; Andreenko GI
    Klin Med (Mosk); 1997; 75(10):55-7. PubMed ID: 9490343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.